Stockscreener 앱 받기
14.82
1.30%
0.19
시간 외 거래:
14.82
Amneal Pharmaceuticals Inc 주식(AMRX)의 최신 뉴스
Is Amneal Pharmaceuticals Inc. forming a double bottomJuly 2025 Snapshot & Capital Efficient Trade Techniques - mfd.ru
Resistance Check: How does Amneal Pharmaceuticals Inc perform in inflationary periodsPortfolio Value Summary & Smart Money Movement Tracker - baoquankhu1.vn
Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market - Benzinga
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Up 87.3% in January - MarketBeat
What Amneal Pharmaceuticals (AMRX)'s Addition to the S&P 1000 Index Means For Shareholders - Yahoo Finance
Options Flow: Can Amneal Pharmaceuticals Inc continue delivering strong returns2025 Technical Patterns & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Is Amneal Pharmaceuticals Inc. in a long term uptrend2025 Momentum Check & Long-Term Growth Portfolio Plans - mfd.ru
Doseology Sciences Launches New Energy Product Line - Intellectia AI
What Amneal Pharmaceuticals (AMRX)'s Index Additions and Opioid Settlement Mean For Shareholders - simplywall.st
Earnings Report: Will Amneal Pharmaceuticals Inc benefit from current market trendsWeekly Risk Report & Verified Momentum Watchlists - baoquankhu1.vn
What are the future prospects of Amneal Pharmaceuticals IncJuly 2025 News Drivers & Fast Gain Stock Tips - baoquankhu1.vn
Amneal Receives FDA Approval for Sodium Oxybate Oral Solution - Sleep Review
Breakouts Watch: What’s the outlook for SPAR Group Inc.’s sectorTrade Analysis Summary & High Win Rate Trade Alerts - baoquankhu1.vn
Is Amneal Pharmaceuticals (AMRX) a Great Value Stock Right Now? - Yahoo Finance
Guidance Update: Is Amneal Pharmaceuticals Inc a strong candidate for buy and holdTrade Analysis Summary & Low Risk Entry Point Guides - baoquankhu1.vn
Amneal Pharmaceuticals Refinances Term Loans, Lowers Interest Costs - TipRanks
Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit AgreementSEC Filing - TradingView
Amneal Pharmaceuticals Signs Term Loan Credit Agreement Amendment With JPMorgan Chase - TradingView
How Investors Are Reacting To Amneal Pharmaceuticals (AMRX) Index Additions And Opioid Settlement Resolution - Sahm
Will Amneal (AMRX) beat estimates again in its next earnings report? - MSN
Amneal initiates nationwide settlement for opioid-related claims - MSN
Aug Sentiment: Is Amneal Pharmaceuticals Inc stock a hidden gem2025 Pullback Review & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Risk Check: Does Ormat Technologies Inc stock benefit from AI growth2025 Market Outlook & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
AustralianSuper Pty Ltd Makes New Investment in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Is It Too Late To Consider Amneal Pharmaceuticals (AMRX) After Its Strong Multi‑Year Share Price Run? - Yahoo Finance
Opioid Settlement And Index Inclusion Reframe Amneal Pharmaceuticals Risk And Reach - Yahoo Finance
Published on: 2026-01-30 06:37:48 - baoquankhu1.vn
Amneal initiates nationwide opioid settlement (AMRX:NASDAQ) - Seeking Alpha
Is It Too Late To Consider Amneal Pharmaceuticals (AMRX) After Its Strong Multi Year Run? - Sahm
Amneal Finalizes Nationwide Opioid Settlement Implementation Plan - TipRanks
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index - The Manila Times
Amneal Pharma To Settle Majority Of Opioids-Related Claims - TradingView
Amneal Pharmaceuticals Finalizes Nationwide Opioids Settlement - TradingView
Amneal Pharmaceuticals, Inc. Added to S&P SmallCap 600® Index - Quiver Quantitative
Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report? - sharewise.com
Amneal Pharmaceuticals (NASDAQ:AMRX) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Amneal Pharmaceuticals, Inc. $AMRX Shares Sold by SG Americas Securities LLC - MarketBeat
TTM Technologies, Dutch Bros to join S&P 400 Index; Amneal, Apellis to be part of S&P SmallCap 600 (CIVI:NYSE) - Seeking Alpha
Amneal, LegalZoom, others rise as S&P Dow Jones Indices announces index changes - Investing.com Canada
Amneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 1-Year HighStill a Buy? - MarketBeat
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026 - The Manila Times
Can Amneal Pharmaceuticals Inc. be the next market leaderWeekly Stock Report & Safe Entry Momentum Tips - mfd.ru
Risk Recap: Can Amneal Pharmaceuticals Inc. be the next market leaderNew Guidance & High Accuracy Swing Entry Alerts - baoquankhu1.vn
2 Reasons to Sell AMRX and 1 Stock to Buy Instead - Finviz
Can Amneal Pharmaceuticals Inc. continue delivering strong returnsJuly 2025 Volume & AI Enhanced Trading Alerts - mfd.ru
Stock Recap: Is ACAD in a bullish channelJuly 2025 Short Interest & Smart Allocation Stock Reports - baoquankhu1.vn
Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Assessing Amneal Pharmaceuticals (AMRX) Valuation After Recent Share Price Momentum - Sahm
Truist raises PT on Amneal Pharmaceuticals (AMRX) to $15 from $14 - MSN
Profit Recap: Is Amneal Pharmaceuticals Inc in a long term uptrend2025 Geopolitical Influence & Advanced Technical Signal Analysis - baoquankhu1.vn
Amneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 12-Month HighHere's Why - MarketBeat
Amneal Pharmaceuticals stock hits 52-week high at $13.48 - Investing.com
Gains Recap: Is Amneal Pharmaceuticals Inc stock undervalued right nowCEO Change & Community Consensus Picks - baoquankhu1.vn
Geopolitics Watch: Should I buy KNTK stock nowWeekly Stock Analysis & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
1.19%
0.83%
자본화:
|
볼륨(24시간):